Sell ABT Stock Ahead Of Its Q2 Earnings?

Abbott Laboratories (ABT) is scheduled to announce its Q2 2025 earnings on July 17, with analysts forecasting EPS of $1.25 on revenues of $11.02 billion, representing growth over last year's figures. Historically, ABT's stock has exhibited a pattern of negative one-day returns following earnings releases in 60% of cases over the past five years, with a median decline of -2.4%. However, positive one-day returns have increased to 50% over the last three years, with a median gain of 3.0%, suggesting nuanced volatility around the upcoming announcement for event-driven traders.

Analysis

Abbott Laboratories (ABT) is approaching its Q2 2025 earnings announcement with consensus analyst estimates projecting year-over-year growth, forecasting earnings per share of $1.25 on revenues of $11.02 billion, compared to $1.14 EPS on $10.38 billion in the prior-year quarter. While the fundamental outlook appears positive, historical post-earnings data presents a more cautious picture for event-driven traders. Over the past five years, ABT's stock has registered a negative one-day return following 60% of its earnings announcements, with a median decline of -2.4%. However, this pattern has shifted more recently; over the last three years, the frequency of positive one-day returns has increased to 50%. Furthermore, the risk-reward profile appears asymmetric, as the median gain on positive days (3.0%) has been larger in magnitude than the median loss on negative days. This statistical backdrop is anchored by the company's solid fundamentals, including a market capitalization of approximately $230 billion, $42 billion in annual revenue, and substantial profitability with $7.1 billion in operating income.

Key Decisions for Investors

• Investors should weigh the strong analyst growth expectations for Q2 against the stock's historical tendency for a negative one-day reaction post-earnings, which has occurred in 60% of cases over the last five years.
• Consider the more recent three-year trend, which shows an even 50/50 split between positive and negative reactions, and note the asymmetric payoff profile where the median gain of 3.0% has historically exceeded the median loss of -2.4%.
• For those seeking to mitigate event risk, a prudent strategy may be to wait for the earnings release and the subsequent one-day return before establishing a medium-term position, as suggested by the article's analysis of return correlations.
• Long-term investors should focus on whether the upcoming results validate the company's strong fundamental profile and growth trajectory, rather than being solely influenced by short-term trading patterns.